Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001513162-18-000319
Filing Date
2018-12-20
Accepted
2018-12-19 17:33:49
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 forms_3.htm S-3 376820
2 EXHIBIT 1.2 exhibit1_2.htm EX-1.2 248176
3 EXHIBIT 4.2 exhibit4_2.htm EX-4.2 1507
4 EXHIBIT 5.1 exhibit5_1.htm EX-5.1 15264
5 EXHIBIT 23.1 exhibit23_1.htm EX-23.1 1587
6 EXHIBIT 23.2 exhibit23_2.htm EX-23.2 2812
7 GRAPHIC image1.jpg GRAPHIC 5007
8 GRAPHIC vxrt.jpg GRAPHIC 33550
9 GRAPHIC vxrtexh42vaxartincstockcert1.jpg GRAPHIC 593907
10 GRAPHIC vxrtexh42vaxartincstockcert2.jpg GRAPHIC 221992
  Complete submission text file 0001513162-18-000319.txt   1824692
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228910 | Film No.: 181244210
SIC: 2836 Biological Products, (No Diagnostic Substances)